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Long-Term Echocardiographic Follow-up after Posterior Mitral 
Annuloplasty Using a Vascular Strip for Ischemic Mitral 
Regurgitation: Ten-Years of Experience at a Single Center
Management of ischemic mitral regurgitation (MR) is challenging. The aim of this study 
was to investigate long-term clinical and echocardiographic results of restrictive mitral 
annuloplasty for ischemic MR. From 2001 through 2010, 96 patients who underwent 
myocardial revascularization with restrictive mitral annuloplasty using a vascular strip for 
ischemic MR were analyzed. Patients were stratified into two groups based on left 
ventricular ejection fraction (LVEF): group I, n = 50, with LVEF > 35% and group II, 
n = 46, with LVEF ≤ 35%. The early mortality rate was 2.1% (2/96) and the late cardiac 
mortality rate was 11.5% (11/96). MR grade was reduced at discharge (0.8 ± 0.7) but 
increased during follow-up (1.1 ± 0.8, P = 0.001). There was no intergroup difference in 
terms of freedom from recurrent MR  ≥  moderate eight years after surgery 
(94.1% ± 5.7%, group I vs 87.8% ± 7.2%, group II; P = 0.575). NYHA functional class 
(odds ratio [OR], 2.2; P = 0.044) and early postoperative residual MR ≥ mild (OR, 25.4; 
P < 0.001) were independent predictors of recurrent MR. Restrictive mitral annuloplasty 
using a vascular strip is effective in ischemic MR. It is important to avoid early 
postoperative residual MR. 
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INTRODUCTION
Ischemic mitral regurgitation (MR) has an incidence of 10% to 
20% in patients with coronary artery disease and is associated 
with poor prognosis (1). The pathophysiology of ischemic MR 
is complex and is related to asymmetric alterations in annular 
and ventricular geometry and function (2). The most common 
surgical treatment is restrictive annuloplasty to increase mitral 
leaflet coaptation by reducing mitral annular diameter (3). How-
ever, recent data show that this procedure is associated with a 
10% to 20% rate of persistent MR soon after operation and a 50% 
to 70% rate of recurrent MR at five years. Furthermore, the pres-
ence of persistent or recurrent MR is associated with higher in-
cidences of heart failure and high mortality (4). 
  Flexible, rigid, partial, and complete rings have been used for 
mitral annuloplasty in order to reduce the recurrence of MR and 
several ventricular procedures focusing on the papillary muscles 
and chorda tendineae have been performed (5, 6). Currently, 
no method has proven successful, although some investigators 
reported good results. Coronary artery bypass surgery with pos-
terior mitral annuloplasty using a vascular strip according to the 
location of leaflet tethering for ischemic MR have been performed 
since 2001 at our institution. 
  The aim of this study was to investigate the clinical outcomes 
of posterior mitral annuloplasty using a vascular strip including 
changes of echocardiographic parameters and to identify pre-
dictors associated with repair failure after the procedure.
MATERIALS AND METHODS
Patients
Between September 2001 and September 2010, 96 patients un-
derwent coronary artery bypass combined with posterior mitral 
annuloplasty using a vascular strip for chronic ischemic MR. 
Chronic ischemic MR in the present study was defined as MR 
lasting two weeks after myocardial infarction with left ventricu-
lar segmental wall motion abnormalities, significant coronary 
artery disease in the territory supplying the wall motion abnor-
mality, and structurally normal mitral leaflets and chordae. Pa-
tients with organic mitral valve disease such as prolapse, rheu-
matic disease, or endocarditis were excluded. All patients had 
coronary artery disease and at least moderate functional isch-Jeong DS, et al.  •  Mitral Annuloplasty for Ischemic Mitral Regurgitation
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emic MR. The severity of MR had been documented by preop-
erative transthoracic echocardiography and confirmed by in-
traoperative transesophageal echocardiography under general 
anesthesia.
  We retrospectively reviewed the data that were prospectively 
collected in a computerized database. Patients were stratified 
into two groups based on left ventricular ejection fraction (LVEF): 
group I, n = 50, with LVEF > 35% and group II, n = 46, with LVEF 
≤ 35%. 
Operative technique
All operations were performed through standard median ster-
notomy. Cardiopulmonary bypass was performed with bicaval 
cannulation under mild hypothermia. Myocardial protection 
was achieved with retrograde cold blood cardioplegia. The mi-
tral valve was exposed via a left atriotomy through the interatrial 
groove. Once the mitral valve was determined to be anatomi-
cally normal and the tethered part was identified, the vascular 
strip was prepared from Dacron artificial vascular graft accord-
ing to the size of the annulus measured from trigone to trigone 
using Carpentier Edward ring sizer. Then, the stitches for the 
posterior annuloplasty were placed (usually nine overlapping 
2-0 Ticron sutures without Teflon felt). Stitches were anchored 
at the vascular strip with consideration for the site of leaflet teth-
ering. Because of the asymmetrical dilatation caused by the leaf-
let tethering (usually in the P3 segment), particular attention was 
paid to ensure that the middle of the vascular strip correspond-
ed to the middle of the posterior annulus. After placement of 
vascular strip, we reinforced the sutures at both commissures 
and the middle of posterior annulus with 5-0 polypropylene in 
all cases to prevent from dehiscence of vascular strip. Mitral valve 
repair was considered successful if there was no or trivial resid-
ual MR (Fig. 1). We thought restrictive posterior annuloplasty 
could be effective when complete revascularization was per-
formed concomitantly. After finishing mitral valve repair, coro-
nary artery bypass grafting was performed in all patients. All pa-
tients underwent complete coronary revascularization. We per-
formed left internal thoracic artery to left anterior descending 
artery grafting in most patients (87/96, 90.6%). The right inter-
nal thoracic artery was harvested and used as a Y composite graft 
to the left internal thoracic artery in 72 patients (75.0%). The in 
situ right gastroepiploic artery was used in 17 patients (17.7%) 
for revascularization for the right coronary territory. The saphe-
nous vein was used as an aortocoronary bypass in 28 patients 
(29.2%) when the right internal thoracic artery was too short to 
reach the right coronary territory or the right gastroepiploic ar-
tery was unusable.
Echocardiographic evaluation
Left ventricular end-systolic and diastolic dimensions were de-
termined in the parasternal long axis view at the base per Amer-
ican Society of Echocardiography guidelines (7). The MR sever-
ity was determined based on the ratio of maximum regurgitant 
jet area to left atrial area on color Doppler imaging. MR grade 
was graded as trivial (1+), mild (2+), moderate (3+), or severe 
(4+) for ratios of 0% to 10%, 10% to 20%, 20% to 40%, and greater 
than 40%, respectively. Recurrence of MR was defined as 2+/4+ 
or greater MR at postoperative time on color-flow Doppler anal-
ysis. Peak early (E) and late (A) diastolic velocities and mitral in-
flow deceleration time were measured using pulse-wave Dop-
pler scanning at the tip of the mitral valve leaflets. Peak early (E´) 
and late (A´) diastolic mitral annular velocities were acquired at 
the septum in the apical four-chamber view. Tricuspid regurgi-
tation (TR) was graded from 1 to 4 corresponding to mild, mod-
erate, and severe regurgitation respectively.
 
Follow-up
Early mortality was defined as death within 30 days after opera-
tion or before discharge. Postoperative events after discharge 
were acquired from medical records, direct telephone interviews 
with patients or their families, or the national registry of birth 
and death data. Cause of death was classified as cardiac (sud-
den death, heart failure, or myocardial infarction) or noncardiac. 
Cardiovascular morbidity was defined as heart failure events, 
endocarditis, hemorrhage, or neurologic complications related 
to thromboembolism. Heart failure events included admission 
for heart failure symptoms, an early hospital visit and the need 
for more cardiac drugs such as diuretics. Follow-up was ended 
on September 30, 2010, and was completed in 100% of patients. 
The median follow-up duration was 47.9 ± 32.5 (maximum, 8.6 
yr) months. 
Statistical analysis
Statistical analysis was performed using SPSS ver. 17.0 (SPSS, 
Chicago, IL, USA). Measurements are expressed as mean ± stan-
dard deviation or as frequency and proportion. Inter-group com-
parisons were performed using the Student’s unpaired t-test for  Fig. 1. Competent mitral valve repair after posterior annuloplasty using a vascular strip.Jeong DS, et al.  •  Mitral Annuloplasty for Ischemic Mitral Regurgitation
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continuous variables or the chi-squared test (Pearson’s χ2 and 
Fisher’s exact tests) for categorical variables. Repeated measures 
ANOVA was used to compare values at different time points. 
Linear regression analysis was used to detect correlations be-
tween variables of interest. Cox regression analyses were per-
formed to identify predictors of mortality and MR recurrence. 
Variables assessed via univariate analysis were age, gender, dia-
betes, hypertension, chronic renal failure, NYHA functional class, 
stroke history, myocardial infarction, left main disease, emer-
gency, atrial fibrillation, number of bypass grafts, use of saphe-
nous vein, and echocardiographic parameters (preoperative 
and late follow-up). Variables with P values < 0.2 on univariate 
analysis were included in the multivariate analysis model. Post-
operative outcomes were analyzed using the curve derived from 
the Kaplan-Meier method, and an inter-group comparisons 
were made using the log-rank test. P values < 0.05 were consid-
ered statistically significant.
Ethics statement
The study protocol was reviewed and approved by the institu-
tional review board of Samsung Medical Center (IRB No. 2010-
12-036). Informed consent was waived by the board.
RESULTS
Baseline characteristics
The baseline and surgical characteristics were compared be-
tween the two groups (Table 1). There were differences in base-
line NYHA class, left ventricular end systolic and diastolic dimen-
sions, and LVEF. Group II patients had a longer bypass time (P =  
0.004) and the saphenous vein was more frequently used dur-
ing coronary artery bypass in group II (P = 0.014).
Clinical follow-up
The early mortality rate was 2.1% (2/96). Both deaths occurred 
in group II, and the cause of death was low cardiac output syn-
drome in both cases. There were no significant differences in 
the incidence of perioperative morbidities such as atrial fibril-
lation, bleeding reoperation, neurologic complications or respi-
ratory complication. The incidences of acute kidney injury and 
postoperative low cardiac output requiring prolonged inotro-
pics longer than three days were higher in group II, the patients 
of which also experienced longer hospital stay. No reoperations 
for residual MR were performed in either group (Table 2).
  There were 11 late cardiac deaths (11.5%). In group I, cardiac 
mortality occurred in seven patients (14%, 7/50), and the causes 
of death included myocardial infarction, congestive heart fail-
ure related to ischemic cardiomyopathy and sudden death. In 
group II, three patients died of congestive heart failure related 
to ischemic cardiomyopathy and one patient died suddenly (8.7%, 
4/46, Table 2). The late morbidity included stroke in one patient, 
arrhythmia requiring hospital admission in two patients and 
heart failure related to moderate to severe MR in five patients. 
No vascular strip related complications such as detachment, 
hemolysis, infective endocarditis or pannus formation occurred. 
During follow-up, the graft patency was evaluated in 24 patients 
with coronary angiography or computed tomographic coronary 
angiography. Graft occlusion was not found in these patients, 
but percutaneous coronary intervention (PCI) was performed 
in one patient for disease progression in the native coronary ar-
tery.
Table 1. Baseline and surgical characteristics of patients
Variables Group I (n = 50) Group II (n = 46) P value
Age (yr)     63.4 ± 10.3 64.5 ± 9.5 0.588
Female, No. (%) 14 (28.0) 13 (28.3) 0.977
NYHA functional class, mean     2.0 ± 0.9   2.5 ± 1.0 0.011
Hypertension, No. (%) 28 (56.0) 25 (54.3) 0.871
Diabetes, No. (%) 26 (52.0) 22 (47.8) 0.838
Chronic renal failure, No. (%)   7 (14.0)   8 (17.4) 0.780
Stroke history, No. (%)   6 (12.0) 10 (21.7) 0.275
MI history, No. (%) 27 (54.0) 27 (58.7) 0.684
Left main disease, No. (%)   6 (12.0)   8 (17.4) 0.566
Atrial fibrillation, No. (%)   9 (18.0)   5 (10.9) 0.393
Echocardiography
   Severe MR, No. (%)
   LVESD (mm)
   LVEDD (mm)
   LVEF (%)
   RVSP (mmHg)
   LAD (mm)
   E/A
   E´/e
   Deceleration time of mitral inflow
 
16 (32.0)
  41.5 ± 7.9
  56.3 ± 5.9
    48.9 ± 10.4
    44.4 ± 14.6
  44.8 ± 6.4
  1.6 ± 1.2
  16.8 ± 5.0
  208.6 ± 62.7
 
13 (28.3)
52.7 ± 5.9
64.5 ± 5.8
28.8 ± 5.3
  45.2 ± 13.1
46.8 ± 6.6
  1.8 ± 1.0
21.5 ± 9.0
160.3 ± 61.3
 
0.824
0.001
0.001
0.001
0.810
0.146
0.503
0.025
0.001
Anastomosis/patient, No.
   Anterior
   Posterior
   Inferior
    3.9 ± 1.3
    1.5 ± 0.7
    1.2 ± 0.6
    1.0 ± 0.6
  4.2 ± 1.2
  1.5 ± 0.5
  1.3 ± 0.8
  1.1 ± 0.6
0.278
0.740
0.395
0.834
Use of saphenous vein, No. (%)   9 (18.0) 19 (41.3) 0.014
CPB time (min)   120.4 ± 29.2 137.4 ± 27.3 0.004
NYHA, New York Heart Association; MR, mitral regurgitation; LVESD, left ventricular 
end-systolic dimension; LVEDD, left ventricular end-diastolic dimension; LVEF, left 
ventricular ejection fraction; RVSP, right ventricular systolic pressure; LAD, Left atrial 
dimension; E/A, the ratio of early filling peak velocity to atrial peak velocity of mitral 
inflow; E´/e, the ratio between early diastolic mitral inflow and mitral annular velocity; 
CPB, cardiopulmonary bypass; ACC, aortic cross clamp.
Table 2. Clinical outcomes
Variables Group I (n = 50) Group II (n = 46) P value
Mortality, No. (%)
   Early
   Late
   Cardiac death
  9 (18)
0 (0)
     9 (18.0)
     7 (14.0)
   11 (23.9)
   2 (4.3)
     9 (19.6)
   4 (8.7)
0.616
0.227
0.999
0.528
Morbidity, No. (%)
   Atrial fibrillation
   Neurologic complications
   Acute kidney injury
   Respiratory complications
   Low cardiac output
 
   16 (32.0)
   3 (6.0)
   2 (4.0)
     5 (10.0)
0 (0)
 
   20 (43.5)
0 (0)
     8 (17.4)
     7 (15.2)
     8 (17.4)
 
0.294
0.243
0.045*
0.543
0.002*
Hospital stay (day) 11.6 ± 7.9 17.2 ± 13.5 0.016
Reoperation for residual MR 0 (0) 0 (0) 0.999
MR, mitral regurgitation.Jeong DS, et al.  •  Mitral Annuloplasty for Ischemic Mitral Regurgitation
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  The overall cumulative survival rate at eight years was 72.9% 
± 5.5% and there was no intergroup difference (77.3% ± 6.8%, 
group I vs 67.5% ± 8.8%, group II; P = 0.438). The proportion of 
patients free from cardiac-related mortality at eight years was 
79.1% ± 4.9%, and there was no intergroup difference (Fig. 2A). 
The overall rate of freedom from mild or greater MR at eight years 
was 68.2% ± 7.5% and there was significant difference between 
groups (Fig. 2B). However, there was no intergroup difference 
in terms of freedom from the presence of moderate or greater 
MR at eight years (Fig. 2C). On the other hand, the rate of free-
dom from the presence of increased MR (more than one grade 
compared with MR at immediate postoperative period) at eight 
years was significantly different between groups (Fig. 2D).
  Emergency operation, preoperative tricuspid regurgitation 
( ≥ mild) and occurrence of recurrent moderate or greater MR 
during follow-up were predictors for cardiac-related mortality. 
Preoperative NYHA functional class and early postoperative re-
sidual MR ≥ mild at discharge were found to be associated with 
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Fig. 2. Kaplan-Meier estimates for survival and recurrence of mitral regurgitation. (A) Freedom from cardiac-related mortality. LVEF, left ventricular ejection fraction. (B) Freedom 
from presence of mild or greater mitral regurgitation (MR). (C) Freedom from presence of moderate or greater mitral regurgitation. (D) Freedom from presence of increased mi-
tral regurgitation. 
Table 3. Multivariate analysis for mortality and recurrent mitral regurgitation
Variables
Mortality
      Variables
Recurrent mitral regurgitation
P value Hazard ratio   95% CI P value Hazard ratio   95% CI
Emergency operation 0.017 22.5     1.7-290.6       LVEF ≤ 35% 0.634
MI history 0.322       Chronic renal failure 0.266
Preoperative TR ≥ mild 0.009 4.7 1.47-15.3       NYHA functional class 0.044 2.2 1.0-4.6
Chronic renal failure 0.591       LVESD 0.252
Atrial fibrillation 0.734       LVEDD 0.687
Hypertension 0.104       MR at discharge ≥ mild  0.001 25.4     3.6-180.8
Recurrent MR ≥ moderate 0.046 20.1   1.05-385.6
CI, confidence interval; MI, myocardial infarction; TR, tricuspid regurgitation; MR, mitral regurgitation; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; 
LVESD, left ventricular end-systolic dimension; LVEDD, left ventricular end-diastolic dimension.Jeong DS, et al.  •  Mitral Annuloplasty for Ischemic Mitral Regurgitation
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an increased risk for recurrent MR during follow-up (Table 3). 
Echocardiographic follow-up
Table 4 presents the echocardiographic findings after operation. 
The left ventricular end systolic dimension, left ventricular end 
diastolic dimension and right ventricular systolic pressure were 
reduced during follow-up in both groups. The LVEF improved 
over time, and this improvement was more prominent in group 
II than in group I (P = 0.025). Tricuspid regurgitation was un-
changed during follow-up in both groups. MR grade was reduced 
at discharge (0.8 ± 0.7) but increased slightly during follow-up 
(1.1 ± 0.8, P = 0.001). This pattern of change was not different 
between groups (P = 0.247). 
  Among the patients with preoperative moderate ischemic 
MR, moderate MR was detected at discharge in one patient who 
had mild MR on intraoperative transesophageal echocardiog-
raphy after posterior annuloplasty. Forty-seven patients (47 of 
63, 74.6%) had no or trivial MR during follow-up, and moderate 
to severe MR developed in four of 63 patients (6.3%). None of 
patients with preoperative severe ischemic MR had moderate 
MR at discharge, and 22 of 28 patients (78.6%) had no or trivial 
MR during follow-up. Only one patient was followed-up with 
recurrent moderate MR. The incidence of MR ≥ mild during fol-
low-up was 24.2% (22/91), and there was no difference in terms 
of preoperative MR severity (moderate vs severe, 16/63 (25.4%) 
vs 6/28 (21.4%), P = 0.683, Fig. 3).
  The mean transmitral pressure gradient was 3.3 ± 1.7 mmHg 
at discharge and 3.7 ± 2.0 mmHg during follow-up. There was 
no intergroup difference in the mean transmitral pressure gra-
dient in either period (P = 0.16).
  Changes in echocardiographic parameters related to left ven-
tricular diastolic function are shown in Fig. 4. The early filling 
peak velocity (E) of mitral inflow increased after mitral valve re-
pair and was maintained during follow-up in both groups. The 
ratio of early filling peak velocity to atrial peak velocity (E/A) of 
mitral inflow decreased after mitral valve repair in both groups 
and increased during follow-up in group II. The ratio between 
early diastolic mitral inflow and mitral annular velocity (E´/e) 
increased after mitral valve repair in both groups and slightly 
decreased during follow-up in group I. The mitral flow deceler-
ation time increased after mitral valve repair in both groups and 
slightly decreased during follow-up in group II. However, none 
of the changes in echocardiographic parameters related to left 
ventricular diastolic function were significantly different between 
groups.
  During follow-up, LVEF was correlated with preoperative E/
A value (r = -0.255, P = 0.019), mitral inflow deceleration time 
(r = -0.243, P = 0.024) and left atrial volume index (r = -0.389, 
P = 0.009). E´/e value during follow-up was correlated with pre-
operative LVEF (r = -0.306, P = 0.010) and left ventricular end 
systolic dimension (r = 0.312, P = 0.009).
DISCUSSION
The results of our study indicate that posterior mitral annulo-
plasty using a vascular strip combined with coronary artery by-
pass is feasible and effective for treating moderate or greater 
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Fig. 3. Serial changes of mitral regurgitation severity during follow-up.
Table 4. Changes of echocardiographic parameters after mitral valve repair
Group I Group II P value
†
LVESD (mm)
   Preoperative
   Discharge
   Follow-up
 
41.5 ± 7.9
40.8 ± 7.5
37.6 ± 6.8*
 
52.7 ± 5.9
49.6 ± 8.8
48.7 ± 10.6*
 
0.531
LVEDD (mm)
   Preoperative
   Discharge
   Follow-up
 
56.3 ± 5.9
54.4 ± 6.0
52.5 ± 6.6*
 
64.5 ± 5.8
60.9 ± 7.4
61.0 ± 7.2*
 
0.545
LVEF (%)
   Preoperative
   Discharge
   Follow-up
 
48.9 ± 10.4
46.6 ± 9.3
49.1 ± 12.0
 
28.8 ± 5.3
33.6 ± 6.5
35.7 ± 13.1*
 
0.025
LAD (mm)
   Preoperative
   Discharge
   Follow-up
 
44.8 ± 6.4
44.0 ± 5.4
44.6 ± 5.9
 
46.8 ± 6.6
46.0 ± 6.2
46.5 ± 6.9
 
0.991
RVSP (mmHg)
   Preoperative
   Discharge
   Follow-up
 
44.4 ± 14.6
36.5 ± 7.2
35.1 ± 8.7*
 
45.2 ± 13.1
38.1 ± 10.3
40.1 ± 14.8*
 
0.532
Mitral regurgitation
   Preoperative
   Discharge
   Follow-up
 
3.3 ± 0.5
0.8 ± 0.7
1.0 ± 0.7*
 
3.3 ± 0.5
0.8 ± 0.6
1.3 ± 0.9*
 
0.247
*P < 0.05 in comparison of parameters between preoperative and follow-up period; 
†P value in comparison of group parameters at multiple time points. LVESD, left ven-
tricular end-systolic dimension; LVEDD, left ventricular end-diastolic dimension; LVEF, 
left ventricular ejection fraction; LAD, left atrial dimension; RVSP, right ventricular 
systolic pressure. Jeong DS, et al.  •  Mitral Annuloplasty for Ischemic Mitral Regurgitation
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ischemic MR with acceptable repair durability. There are three 
important points to be considered based on our findings. First, 
late cardiac-related mortality was not associated with the pre-
operative LVEF but with recurrent moderate MR during follow-
up. Second, postoperative MR severity was reduced at discharge 
but increased during follow-up irrespective of preoperative MR 
severity. Third, the most important predictor of recurrent MR 
was early postoperative MR.
  The detrimental effects of ischemic MR leading to heart fail-
ure and high mortality are well documented (1). In the past, cor-
onary revascularization was believed to correct ischemic MR by 
improving left ventricular function (8). However, observational 
studies have demonstrated that revascularization alone does 
not resolve MR (9). Although some studies have reported that 
coronary artery bypass surgery combined with mitral valve re-
pair shows better outcomes in terms of MR recurrence than cor-
onary artery bypass surgery alone, controversy remains regard-
ing operative risk and survival benefit. Grossi et al. (10) reported 
an early mortality rate of 13.4% in ischemic MR patients with a 
five-year survival of 71% after mitral valve repair. Gillinov et al. 
(11) found an early mortality of 13%, and Kang et al. (12) report-
ed an operative mortality of 12% in Korean patients undergoing 
mitral valve repair. They also found that mitral valve repair was 
superior in patients with severe MR and did not increase opera-
tive or late mortality rate compared to coronary artery bypass 
surgery alone. However, in patients with moderate MR, the op-
erative mortality rate of mitral valve repair was higher than that 
of coronary artery bypass surgery alone, whereas the MR im-
provement rates were similar for the two procedures. Yu et al. 
(13) reported a similar result. Recently, the early results of mitral 
valve repair in patients with ischemic MR have been improved 
over time as the mechanisms of ischemic MR have become bet-
ter understood. Szalay et al. (14) reported an early mortality rate 
of 6.6% with an 85% survival rate at three years in 91 patients with 
ischemic cardiomyopathy and moderate to severe MR who un-
derwent coronary artery bypass surgery and mitral valve repair. 
In the present study, early mortality occurred in two patients 
(2.1%), and this is comparable to the operative mortality of 2.4% 
for mitral valve repair reported by Calafiore et al. (15).
  Poor outcomes are related to left ventricular damage as a con-
sequence of remodeling in ischemic MR, and this damage can 
be successfully remedied with a relatively simple procedure per-
formed on the mitral annulus, that is, undersized annuloplasty 
which was popularized by Bolling et al. (3). However, some sur-
gical series showed that recurrent MR occurs in one third of pa-
tients during follow-up (4, 16). Recently, techniques for reduc-
ing the incidence of late recurrent MR have been attempted, in-
cluding annuloplasty using different rings such as asymmetric, 
rigid, flexible, complete, or partial rings and procedures at the 
level of the left ventricle, papillary muscles or tethered leaflets 
(5, 6). Randomized data on the results of these repair techniques 
are lacking, and results of observational studies are not consis-
tent. In our series, a vascular strip was used for restrictive poste-
rior annuloplasty due to its many advantages including ease to 
handling, high cost effectiveness, semi-rigid ring effect and wide 
availability. The rate of freedom from moderate or greater MR 
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at eight years was 85.1% ± 8.3% in our cohort, comparable to 
that reported by Wong et al. (17).
  A reduction in left ventricular dimension is associated with 
favorable clinical outcome. Bax et al. (18) performed a serial 
echocardiographic assessment of left ventricular dimensions 
after mitral valve repair and found that left ventricular reverse 
remodeling is a gradual and time-dependent process. Accord-
ing to that report, regression of the left ventricular end systolic 
dimension was observed in 73% of patients and the left ventric-
ular end diastolic dimension was reduced in 55% (less frequent). 
In the present study, we found that the left ventricular dimen-
sions were diminished irrespective of LVEF, but the left ventric-
ular dimensions during follow-up were greater in patients with 
LVEF above 35% than those with LVEF ≤ 35%. Patients with LVEF 
less than 35% in our series were characterized by greater left ven-
tricular dimensions at baseline. Braun et al. (19) found that a 
preoperative left ventricular end diastolic dimension of 65 mm 
or less or a left ventricular end systolic dimension of 51 mm or 
less was predictive of reverse remodeling. These findings may 
suggest that severe left ventricular dilatation may be an irrevers-
ible process, and surgery should be performed before severe 
dilatation has occurred. We did not observe any changes in the 
left atrial dimension before and after mitral valve repair.
  Although there is active debate as to whether mitral valve re-
pair will affect survival, there are few data about the importance 
of residual or recurrent ischemic MR. Hausmann et al. (20) re-
ported reduced survival in patients undergoing mitral valve re-
pair with revascularization in whom MR grade I or higher re-
mained and this result is consistent with that of our analysis. Ac-
cording to our study, one of the independent predictors of mor-
tality was recurrent moderate or greater MR after surgical cor-
rection.
  Previous efforts to identify predictors of recurrent MR after 
surgical correction have been demonstrated. The observational 
study by Penicka et al. (21) revealed that reliable improvement 
in moderate ischemic MR after isolated coronary artery bypass 
surgery was related to the presence of viable myocardium and 
the absence of dyssynchrony between papillary muscles. Braun 
et al. (19) found that the preoperative left ventricular dimensions 
were related to MR recurrence and reverse remodeling, and Kong-
saerepong et al. (22) determined that higher MR severity, larger 
mitral annular diameter, and greater tethering area are inde-
pendent predictors of mitral valve repair failure. In the present 
study, higher preoperative NYHA functional class and residual 
MR ( ≥ mild) were independent predictors of recurrent MR dur-
ing follow-up. However, preoperative left ventricular function 
and dimensions were not significant on multivariate analysis. 
Based on these results, we can infer that complete elimination 
of MR during operation is important in preventing MR recur-
rence despite poor left ventricular function and dilated left ven-
tricular dimensions. 
  In terms of operative technique of mitral annuloplasty using 
a vascular strip, no vascular strip related complications occurred 
and no reoperation for MR was performed. Five patients had 
moderate or severe MR during follow-up and the cause was teth-
ering of leaflet due to the left ventricular dilatation in all patients. 
It seems that mitral annuloplasty using a vascular strip is not 
associated with MR aggravation in our series. However, further 
studies are required to reveal the correlation between the oper-
ative technique using vascular strips and MR aggravation.
  Some authors have performed an aggressively undersized 
annuloplasty in order to reduce the incidence of recurrent MR 
and have achieved excellent mitral valve competence (3). How-
ever, concerns have also been raised with regard to the poten-
tial for an aggressive annuloplasty to lead to increased transmi-
tral pressure gradients, which could have a deleterious effect on 
clinical outcomes (23), and this issue remains controversial (24). 
In our series, the mean transmitral pressure gradient was 3.3 ±  
1.7 mmHg at discharge and remained stable during follow-up 
(3.7 ± 1.9 mmHg, P = 0.17).
  The E´/e ratio is a powerful predictor of survival in patients 
with ischemic heart disease (25). Bruch et al. (26) validated the 
use of E´/e for estimating filling pressures in patients with isch-
emic MR. They found that an E´/e ratio > 15 had 80% sensitivity 
and 100% specificity for predicting a left ventricular end-dia-
stolic pressure ≥ 15 mmHg. In the present study, the E´/e ratio 
was measured in all 76 survivors with a follow-up interval of 
2.5 ± 2.2 (maximum, 8.2 yr) years. The mean preoperative E´/e 
was 29.9 ± 14.3. While the preoperative left atrial volume index, 
left atrial dimension and left ventricular end diastolic dimension 
were not correlated with E´/e during follow-up, while preoper-
ative LVEF and left ventricular end systolic dimension were. Dur-
ing follow-up, LVEF was correlated with preoperative E/A, mi-
tral inflow deceleration time and left atrial volume index. Based 
on these results, we suggest that early mitral valve repair should 
be considered in patients with left ventricular dysfunction and 
dilation of the left ventricular end systolic dimension in order to 
relieve further left ventricular diastolic dysfunction in moderate 
ischemic MR.
  Several limitations of the present study should be mentioned. 
First, this study is inherently limited by its retrospective nature. 
However, all patients in our series underwent the same surgical 
procedures: complete revascularization and mitral annuloplas-
ty using vascular strips of the same length. Moreover, the echo-
cardiographic follow-up protocol was homogeneous in most 
patients as it was performed at the same institution albeit at dif-
ferent intervals. We believe that data collection errors were min-
imized for these reasons. Second, more detailed echocardio-
graphic data such as coaptation height, tenting area, and teth-
ering height were not available because these were not routine-
ly measured in the past. Inclusion of a myocardial viability as-
sessment could likely have improved the present study. How-Jeong DS, et al.  •  Mitral Annuloplasty for Ischemic Mitral Regurgitation
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ever, myocardial viability was only tested in recent patients. The 
third limitation is in the statistical analysis. The echocardiograph-
ic parameters were not measured at the same point in time for 
all patients during follow-up. Therefore, direct comparisons of 
the parameters at the three points in time (preoperatively, at 
discharge, and at follow-up) may not be appropriate. However, 
our focus was primarily on changes and correlations between 
parameters during follow-up.
  In conclusion, restrictive posterior mitral annuloplasty using 
a vascular strip combined with coronary artery bypass is feasi-
ble and effective for treating moderate or greater ischemic MR 
with acceptable repair durability. It is important to avoid early 
postoperative residual MR. Furthermore, early mitral valve re-
pair may be helpful for patients with left ventricular dysfunction 
and dilation of the left ventricular end systolic dimension.
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AUTHOR SUMMARY
Long-Term Echocardiographic Follow-up after Posterior Mitral Annuloplasty Using 
a Vascular Strip for Ischemic Mitral Regurgitation: Ten-Years of Experience at a 
Single Center
Dong Seop Jeong, Hae Young Lee, Wook Sung Kim, Kiick Sung, Tae-Gook Jun, Ji-Hyuk Yang, Pyo Won Park and Young Tak Lee
Surgical treatment of ischemic mitral regurgitation (MR) using restrictive annuloplasty required further investigation, and recent 
data showed that this procedure might be associated with late recurrent MR. Here we investigate the clinical and echocardiographic 
outcomes of posterior mitral annuloplasty with vascular strip. Our study indicated mitral annuloplasty with vascular strip is effective 
in ischemic MR with acceptable durability. The late cardiac-related mortality was associated with not the preoperative LVEF but 
recurrent moderate MR at follow up and the important factor of recurrent MR was early postoperative residual MR.